COMPASS Trial: a Direct Aspiration First Pass Technique "COMPASS"

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of AIS within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours. Mechanical thrombectomy for AIS patients has been shown in clinical trials to be safe up to 8 hours after symptom onset. Recent trials utilizing advanced imaging to identify patients with...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 September 2017.

1 Jun 2015 10 Apr 2015 1 Jul 2017 1 Jul 2018 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts